Divergent associations of slow-wave sleep vs. REM sleep with plasma amyloid-beta
Yevgenia RosenblumiD, Mariana PereiraiD, Oliver Stange, Frederik D. WeberiD, Leonore BovyiD, Sofia TzioridouiD, Elisa LanciniiD, David A. NevilleiD, Nadja KleiniD, Timo de WolffiD, Mandy Stritzke, Iris KersteniD, Manfred Uhr, Jurgen A.H.R. ClaasseniD, Axel SteigeriD, Marcel M. VerbeekiD, Martin DresleriD
Abstract
BackgroundRecent evidence shows that during slow-wave sleep (SWS), the brain is cleared from potentially toxic metabolites, such as the amyloid-beta protein. Poor sleep or elevated cortisol levels can worsen amyloid-beta clearance, potentially leading to the formation of amyloid plaques, a neuropathological hallmark of Alzheimers disease. Here, we explore how nocturnal neural and endocrine activity affects amyloid-beta fluctuations in the peripheral blood as a reflection of cerebral clearance. MethodsSimultaneous polysomnography and all-night blood sampling were acquired in 60 healthy volunteers aged 20-68 years old. Nocturnal plasma concentrations of two amyloid-beta species (amyloid-beta-40 and amyloid-beta-42), cortisol, and growth hormone were assessed every 20 minutes from 23:00-7:00. Amyloid-beta fluctuations were modeled with sleep stages, (non)-oscillatory power, and hormones as predictors while controlling for age and multiple comparisons. Time lags between the predictors and amyloid-beta ranged from 20 to 120min. FindingsThe amyloid-beta-40 and amyloid-beta-42 levels correlated positively with growth hormone concentrations, SWS proportion, slow-wave (0.3-4Hz) oscillatory and high-band (30-48Hz) non-oscillatory power, but negatively with cortisol concentrations and rapid eye movement sleep (REM) proportion measured 40-100min before (all t-values>|3|, p-values<0.003). Older participants showed higher amyloid-beta-40 levels. InterpretationSlow-wave oscillations are associated with higher plasma amyloid-beta levels, reflecting their contribution to cerebral amyloid-beta clearance across the blood-brain barrier. REM sleep is related to decreased amyloid-beta plasma levels; however, this link may reflect passive aftereffects of SWS and not REMs effects per se. Strong associations between cortisol, growth hormone, and amyloid-beta presumably reflect the sleep-regulating role of the corresponding releasing hormones. A positive association between age and amyloid-beta-40 may indicate that peripheral clearance becomes less efficient with age. Our study provides important insights into the specificity of different sleep features effects on brain clearance and suggests that cortisol nocturnal fluctuations may serve as a new marker of clearance efficiency.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 2
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Enhancing slow-wave sleep via non-invasive brain stimulation modulates brain-to-blood clearance of Alzheimer's disease biomarkers
Julia Ladenbauer, Paula Schuemann, … Agnes Flöel·bioRxiv·Jun 28, 2026
- Quantitative Modelling of Amyloid-β Dynamics in Brain, CSF, and Plasma During Sleep and Wakefulness
Satyam Sangeet, Craig L. Phillips, … Svetlana Postnova·bioRxiv·Sep 14, 2026
- Amyloid fibrils in Alzheimer's disease differently modulate sleep and cortical oscillations in mice depending on the type of amyloid
Tomomi Sanagi, Masaki Okumura, … Tomomi Tsunematsu·Biophysical ChemistryPeer-reviewed·Feb 25, 2026
- Slow Wave Sleep Reduces CSF Concentrations of Beta-amyloid and Tau: A Randomized Crossover Study in Healthy Adults
Tim Lyckenvik, Martin Olsson, … Eric Hanse·bioRxiv·Jun 15, 2025
- Longitudinal increase in sleep problems is related to amyloid deposition in cortical regions with high HOMER1 gene expression
Anders M. Fjell, Donatas Sederevičius, … Alzheimer’s Disease Neuroimaging Initiative·Cerebral CortexPeer-reviewed·Sep 5, 2019
- Mapping Sleep's Oscillatory Events as a Biomarker of Alzheimer's Disease
Rachelle L. Pulver, Eugene Kronberg, … Brice V. McConnell·Alzheimer s & DementiaPeer-reviewed·Aug 23, 2023